Publications and Lectures

Boyle, P.C., Pandalache, C., Turczynski, C. Successful Pregnancy Using Oral DHEA Treatment for Hypoandrogenemia in a 30-Year-Old with 5 Recurrent Miscarriages, Including Fetal Demise at 24 weeks: A Case Report. 2024. Front Med (Lausanne). Feb 15;11:1358563.

Boyle, P.C., Toth, A., O’Neill, L., and Turczynski, C. Restorative Reproductive Medicine: An Emerging New Treatment Process and a Prerequisite to Assisted Reproductive Technology for Treatment of Infertility. 2024. Preprints.org. Jan 8.

Boyle, P.C., Andralojc, K., van der Velden, S., Najmabadi, S., de Groot, T., Turczynski, C.J., and Stanford, J.B. Restoration of Serum Estradiol and Reduced Incidence of Miscarriage in Patients with Low Serum Estradiol During Pregnancy: A Retrospective Cohort Study Using a Multifactorial Protocol Including DHEA 2024 Frontiers in Reproductive Health Vol 5:1321284.

Turczynski, C.J, Dodd, A.N., and Urlakis, M.A. Assisted Reproductive Technology and Natural Law: How Seven Years as an Embryologist Revealed IVF’s Disordered Approach to Patient Care. 2022 The Linacre Quarterly Vol 89 (4) pp. 388-403.

Robeck, T.R., Fitzgerald, L.J., Hnida, J.A., Turczynski, C.J., Smith, D. and Kraemer, D.C. Analysis of Urinary Progesterone Metabolites with Behavioral correlation in Guenther’s dik-dik (Madoqua guentheri). 1997 J. Zoo Wildlife Medicine.  Vol 28 (4) pp. 434-442.

May, J.V., Stephenson, L.A., Turczynski, C.J., Fong, H.W. Mau, Y.H. and Davis, J.S. Transforming Growth Factor-Beta Expression in the Porcine Ovary: Evidence that Theca Cells are the Major Secretory Source During Antral Follicle Development. 1996 Biol. Reprod. Vol 54, (2) pp. 485.

THE ENDOCRINOLOGY OF MUSTH IN THE MALE ASIATIC ELEPHANT (Elephas maximus): SERUM ESTRADIOL, SERUM LH AND SERUM, FECAL AND URINARY TESTOSTERONE A Dissertation by Craig Turczynski. May 1993. DOI:10.13140/RG.2.2.35949.46565

Bear Woznick: https://www.youtube.com/watch?v=W7TXLKNepVU 

Catholic Answers with Cy Kellett 

https://www.catholic.com/audio/caf/the-practice-and-morality-of-in-vitro-fertilization